Medication governance in NSW workers' compensation

Regulatory framework, SIRA guidance, and best practice medication management

Published: 2026-04-03

Introduction

The State Insurance Regulatory Authority (SIRA) sets the regulatory framework for workers compensation in New South Wales. Within this framework, medication governance is a critical component of claims management, cost control, and outcomes. This article outlines the key regulatory requirements, SIRA guidance on medication management, and best practice approaches for managing medication costs and safety in NSW workers compensation claims.

The SIRA regulatory framework

Workers Compensation Act 1987 and Regulation

The Workers Compensation Act 1987 (NSW) establishes the framework for workers compensation insurance. The Act requires workers compensation insurers to cover medical and pharmaceutical expenses incurred in treating work-related injuries. The Regulation sets out procedural requirements, including requirements around the approval of medical expenses.

SIRA Guidelines on medication management

SIRA has issued guidance on claims management in NSW workers compensation, including guidance on medication management. The guidance emphasises the importance of early intervention, appropriate medication selection, monitoring, and deprescribing where appropriate. Insurers are expected to manage medication costs while ensuring claimants receive appropriate and necessary treatment.

The role of the insurer in medication governance

Under the Workers Compensation Act, the insurer has a duty to cover reasonable and necessary treatment for work-related injuries. This includes medications. However, the insurer also has a responsibility to manage costs and ensure that treatment is appropriate. This creates a balance between providing access to necessary medications and managing costs.

Key medication governance issues in NSW workers compensation

Medication appropriateness and indication

The first governance issue is ensuring that prescribed medications are indicated for the work-related condition. Claims disputes often arise over whether medications are appropriately indicated. For example, if a claimant with a work-related knee injury is prescribed antidepressants, the insurer may question whether this is appropriately related to the compensable injury or whether it is treatment of a pre-existing condition.

Best practice involves early assessment of the relationship between prescribed medications and the work-related condition. Where the relationship is unclear, pharmacist review can clarify whether prescribing is appropriate and appropriate for coverage.

Cost management and prescribing

Medication costs are a significant component of total claims costs. Controlling medication costs while ensuring appropriate treatment is a central challenge. This requires monitoring prescribing for high-cost medications, identifying opportunities for cost-effective alternatives, and deprescribing where appropriate.

Medication safety and monitoring

Insurance claims often involve chronic medication use. Ensuring adequate monitoring for adverse effects and therapeutic efficacy is essential. Claims should include monitoring plans for medications requiring regular checks, and insurers should track whether monitoring occurs.

Polypharmacy and interaction management

As claims extend over longer periods, claimants may accumulate medications from multiple treating doctors. Managing polypharmacy and ensuring that drug-drug interactions are identified and managed is a governance priority.

SIRA-endorsed best practices

Medication governance frameworks

Prior approval and notification requirements

Some medications may require prior approval from the insurer before being covered. High-cost medications, medications that are off-label or not first-line, and medications outside the scope of workers compensation coverage may require approval. Clear policies on prior approval reduce disputes and ensure medication decisions are made collaboratively.

Guidelines and protocols

Best practice involves developing clear medication management guidelines and protocols. These should specify which medications require prior approval, which therapeutic classes require monitoring, expectations for deprescribing, and procedures for managing medication disputes with treating doctors.

Monitoring and escalation

Claims should include regular monitoring of medication regimens. Automated alerts for high-cost medications, long-term opioid use, or other red flags trigger escalation and review. This enables proactive management rather than reactive response to problems.

Medication disputes and resolution in NSW

Common points of dispute

Disputes frequently arise over medication appropriateness, relationship to the compensable injury, costs, and whether medications should be covered under workers compensation. Clear processes for managing these disputes reduce friction and ensure decisions are made fairly.

Role of pharmacist expertise

When disputes arise, pharmacist expert evidence is invaluable. An independent medication review can clarify whether prescribed medications are indicated, whether they are related to the compensable injury, and whether they represent appropriate treatment. This evidence supports fair dispute resolution.

Conclusion

Medication governance in NSW workers compensation requires balancing access to appropriate treatment with cost management and safety. SIRA guidance supports early intervention, pharmacist-led review, therapeutic guideline alignment, and structured deprescribing. By implementing best practice medication governance frameworks, NSW workers compensation insurers can improve claimant outcomes, manage costs, and reduce medication-related risks. Pharmacist-led medication review is a key tool in achieving these objectives.